Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Latex Hypersensitivity D020315 1 associated lipids
Stroke D020521 32 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Tobelem G et al. Further studies on a specific platelet antibody found in Bernard-Soulier syndrome and its effects on normal platelet function. 1979 Br. J. Haematol. pmid:427045
Ford I et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. 1993 Br. J. Haematol. pmid:8338784
Yardumian DA et al. Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374. 1985 Br. J. Haematol. pmid:2408653
Cartwright IJ et al. A haemorrhagic platelet disorder associated with altered stimulus-response coupling and abnormal membrane phospholipid composition. 1994 Br. J. Haematol. pmid:7803235
Dragani A et al. Clinical and laboratory phenotype associated with the aspirin-like defect. 2010 Br. J. Haematol. pmid:19814736
Coppola A et al. Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. 2005 Br. J. Haematol. pmid:16173969
Russell NH et al. Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity. 1979 Br. J. Haematol. pmid:570847
Borowska A et al. Impairment of primary haemostasis by low molecular weight heparins in rats. 1988 Br. J. Haematol. pmid:3355792
Walker ID et al. A double blind study of prostacyclin in cardiopulmonary bypass surgery. 1981 Br. J. Haematol. pmid:6457624
Defreyn G et al. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. 1981 Br. J. Haematol. pmid:6268139
Jakubowski JA et al. Cumulative antiplatelet effect of low-dose enteric coated aspirin. 1985 Br. J. Haematol. pmid:3927970
Lagarde M et al. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. 1978 Br. J. Haematol. pmid:205238
Dubé JN et al. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. 2001 Br. J. Haematol. pmid:11442478
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Altieri DC et al. von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation. 1986 Br. J. Haematol. pmid:2942172
Jackson CA et al. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. 1982 Br. J. Haematol. pmid:6810912
Faili A et al. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation. 1994 Br. J. Haematol. pmid:7803237
Cunnane SC et al. n-3 Essential fatty acids decrease weight gain in genetically obese mice. 1986 Br. J. Nutr. pmid:3676212
Aukema HM et al. Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. 2013 Br. J. Nutr. pmid:23151363
Chiu HF et al. Mechanisms involved in the antiplatelet effect of C-phycocyanin. 2006 Br. J. Nutr. pmid:16469164
Luceri C et al. p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. 2007 Br. J. Nutr. pmid:17313706
Coates AM et al. Regular consumption of n-3 fatty acid-enriched pork modifies cardiovascular risk factors. 2009 Br. J. Nutr. pmid:18590592
Correa JA et al. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. 2009 Br. J. Nutr. pmid:18775097
Sanders TA and Hochland MC A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids. 1983 Br. J. Nutr. pmid:6639916
Trefiletti G et al. 1-Phenyl-6,7-dihydroxy-isochroman suppresses lipopolysaccharide-induced pro-inflammatory mediator production in human monocytes. 2011 Br. J. Nutr. pmid:21269535
Elliott GR et al. The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages. 1990 Br. J. Nutr. pmid:2171633
Berrougui H et al. Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. 2004 Br. J. Nutr. pmid:15613254
Canales A et al. Platelet aggregation, eicosanoid production and thrombogenic ratio in individuals at high cardiovascular risk consuming meat enriched in walnut paste. A crossover, placebo-controlled study. 2009 Br. J. Nutr. pmid:19068151
Ren R et al. Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown alga Laminaria japonica in human subjects. 2013 Br. J. Nutr. pmid:23374164
De La Cruz JP et al. Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus. 2010 Br. J. Nutr. pmid:20350343
D'Orléans-Juste P et al. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. 1991 Br. J. Pharmacol. pmid:1797310
Landucci EC et al. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. 1995 Br. J. Pharmacol. pmid:7537590
Fitzpatrick TM et al. Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog. 1980 Br. J. Pharmacol. pmid:7000216
McMillan RM et al. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase. 1992 Br. J. Pharmacol. pmid:1334748
Juan H et al. Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis. 1987 Br. J. Pharmacol. pmid:2881590
Bennett A and Sanger GJ Trimethoquinol selectively antagonises longitudinal muscle contractions of rat isolated gastric fundus to thromboxane B2 and epoxymethano analogues of PGH2 [proceedings]. 1979 Br. J. Pharmacol. pmid:526738
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Randon J et al. Blockade by methylation inhibitors of the anaphylactic response of guinea-pig lung strips. 1987 Br. J. Pharmacol. pmid:2447992
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Bishop-Bailey D et al. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. 1997 Br. J. Pharmacol. pmid:9146896
Grassi-Kassisse DM et al. Modulation by endogenous prostanoids of the vasoconstrictor activity of endothelin-1 in the canine isolated, perfused spleen. 1994 Br. J. Pharmacol. pmid:7858855
Provost P et al. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. 1998 Br. J. Pharmacol. pmid:9489613
Hugli TE and Marceau F Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. 1985 Br. J. Pharmacol. pmid:3921089
Giembycz MA et al. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma. 1993 Br. J. Pharmacol. pmid:8385538
Yin K et al. Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil. 1991 Br. J. Pharmacol. pmid:1855129
Elliott GR et al. Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. 1989 Br. J. Pharmacol. pmid:2538186
Davidson EM et al. The release of thromboxane B2 by rabbit peritoneal polymorphonuclear leucocytes [proceedings]. 1978 Br. J. Pharmacol. pmid:667479
Panara MR et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. 1995 Br. J. Pharmacol. pmid:8581280
Coker SJ et al. Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. 1981 Br. J. Pharmacol. pmid:7284679
Kadiri C et al. Guinea-pig treatment with pertussis toxin suppresses macrophage-dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF. 1992 Br. J. Pharmacol. pmid:1334747
Cuthbert AW et al. Mediators of the secretory response to kinins. 1984 Br. J. Pharmacol. pmid:6331559
Desquand S et al. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. 1991 Br. J. Pharmacol. pmid:1285397
De La Cruz JP et al. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. 1999 Br. J. Pharmacol. pmid:10602334
Ritter JM Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. 1984 Br. J. Pharmacol. pmid:6386089
Gordon D et al. Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects of mitogen-stimulated lymphocyte proliferation. 1981 Br. J. Pharmacol. pmid:7317694
Ciabattoni G et al. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. 1993 Br. J. Pharmacol. pmid:8495242
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
De La Cruz JP et al. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. 2002 Br. J. Pharmacol. pmid:12429581
Sheu JR et al. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. 2004 Br. J. Pharmacol. pmid:15289295
Giuliano F and Warner TD Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. 1999 Br. J. Pharmacol. pmid:10372826
Moroney MA et al. Differential regulation of 5-lipoxygenase and cyclo-oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes. 1990 Br. J. Pharmacol. pmid:2178012
Gao YJ and Lee RM Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. 2001 Br. J. Pharmacol. pmid:11739239
Feuerstein N et al. Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. 1981 Br. J. Pharmacol. pmid:6894882
Bombardieri S et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 1981 Br. J. Pharmacol. pmid:6895043
Flower RJ et al. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. 1986 Br. J. Pharmacol. pmid:3006856
Huntjens DR et al. Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers. 2006 Br. J. Pharmacol. pmid:16682968
Brunelleschi S et al. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. 1992 Br. J. Pharmacol. pmid:1281723
Pretolani M et al. Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea-pigs. 1992 Br. J. Pharmacol. pmid:1380388
Failli P et al. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 1998 Br. J. Pharmacol. pmid:9579743
Alster P and Wennmalm A Effect of nicotine on the formation of prostacyclin-like activity and thromboxane in rabbit aorta and platelets. 1984 Br. J. Pharmacol. pmid:6367870
Chang MC et al. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. 2007 Br. J. Pharmacol. pmid:17641677
Milara J et al. Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. 2010 Br. J. Pharmacol. pmid:20698855
Anderegg K et al. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat. 1983 Br. J. Pharmacol. pmid:6687819
Ambler J et al. CGS 12970: a novel, long acting thromboxane synthetase inhibitor. 1985 Br. J. Pharmacol. pmid:2932197
Matz RL et al. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. 2000 Br. J. Pharmacol. pmid:10991924
Xu Y et al. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. 2009 Br. J. Pharmacol. pmid:19572944
Zhao L et al. Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. 2009 Br. J. Pharmacol. pmid:19220291
Cano JP et al. Molsidomine prevents post-ischaemic ventricular fibrillation in dogs. 1986 Br. J. Pharmacol. pmid:3755634
Booth RF et al. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. 1989 Br. J. Pharmacol. pmid:2522336
Higgs GA et al. The source of thromboxane and prostaglandins in experimental inflammation. 1983 Br. J. Pharmacol. pmid:6652359
Hay DW et al. Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. 1993 Br. J. Pharmacol. pmid:7507780
Rho MC et al. Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. 1995 Br. J. Pharmacol. pmid:7582454
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
De Kimpe SJ et al. Bovine polymorphonuclear leukocytes increase sensitivity to noradrenaline in isolated mesenteric arteries. 1992 Br. J. Pharmacol. pmid:1628145
Fujii Y and Sakurai J Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism. 1989 Br. J. Pharmacol. pmid:2497921
Holgate ST and Robinson C 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. 1984 Br. J. Pharmacol. pmid:6439267
Sahota T et al. Model-based prediction of the acute and long-term safety profile of naproxen in rats. 2015 Br. J. Pharmacol. pmid:25884765
Hoult JR and Robinson C Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung. 1983 Br. J. Pharmacol. pmid:6824820
Edwards JS and Ritter JM Effect of cytoplasmic pH on Ca(2+)-stimulated eicosanoid biosynthesis in human platelets. 1994 Br. J. Pharmacol. pmid:7858887
Gray PA et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. 2002 Br. J. Pharmacol. pmid:12429575
Sheu JR et al. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. 1999 Br. J. Pharmacol. pmid:10455267
Jiménez R et al. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. 1999 Br. J. Pharmacol. pmid:10455307
Hatmi M et al. Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics. 1991 Br. J. Pharmacol. pmid:1665743
Mallarkey G and Smith GM In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs. 1984 Br. J. Pharmacol. pmid:6423018
Förster W and Pönicke K Influence of sympathomimetic drugs (1-phenyl-2-amino-ethan-1-ol derivatives) on the biosynthesis of prostaglandins and thromboxane B2. 1983 Br. J. Pharmacol. pmid:6403094
Bennett A et al. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo. 1985 Br. J. Pharmacol. pmid:3840708
de Sotomayor MA et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. 2005 Br. J. Pharmacol. pmid:16231003
Chu ZM and Beilin LJ Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. 1993 Br. J. Pharmacol. pmid:8358537
Yeh CH et al. Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. 2001 Br. J. Pharmacol. pmid:11181425
Emms H and Lewis GP The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat. 1986 Br. J. Pharmacol. pmid:3082399